Kyleena 19.5 MG systems
Ended Awarded
- Contract number
- SPE2DB25FH5CJ
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $17,107
Award facts
- Contract value 100% obligated
- $17,106.90 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $17,106.90 by the Defense Logistics Agency on July 21, 2025, for Kyleena 19.5 mg contraceptive systems. The contract, which carries no set-aside designation, utilizes firm fixed-price pricing and is scheduled for completion by August 11, 2025. This delivery order is issued under DMS Pharmaceutical Group's existing single-award Indefinite Delivery Contract with the DLA under the SPE2DB program, a $499.999 billion vehicle that enables the agency to procure a comprehensive range of pharmaceutical products supporting military healthcare facilities worldwide.
As a pharmaceutical wholesaler with an established federal contracting history since 2001, DMS Pharmaceutical Group serves as a critical supplier within the Department of Defense pharmaceutical supply chain, distributing prescription medications, biologics, and medical consumables to military health facilities. The Kyleena delivery represents one of numerous pharmaceutical product orders the company fulfills through its DLA relationship, which spans contraceptive devices, oncology treatments, vaccines, and specialty medications. The contract's firm fixed-price structure and expedited completion timeline underscore the routine nature of supply orders under the larger IDC framework that governs DMS Pharmaceutical Group's ongoing relationship with the Defense Logistics Agency.
Quick answers
Who was awarded contract SPE2DB25FH5CJ?
SPE2DB25FH5CJ was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on July 21, 2025.
How much is contract SPE2DB25FH5CJ worth?
The government has obligated $17,107 on SPE2DB25FH5CJ.
Is contract SPE2DB25FH5CJ an order under another contract?
Yes. SPE2DB25FH5CJ is a delivery order under SPE2DB22D9207, an indefinite delivery contract.
Was contract SPE2DB25FH5CJ competed?
The extent of competition for SPE2DB25FH5CJ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award